V-Square Quantitative Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$967K Buy
2,609
+167
+7% +$59K 0.09% 201
2026
Q2
$877K Sell
2,442
-246
-9% -$75.2K 0.08% 213
2026
Q1
$674K Buy
2,688
+351
+15% +$87.3K 0.07% 243
2025
Q4
$643K Buy
+2,337
New +$639K 0.07% 251
2025
Q3
– Sell
-2,486
Closed -$544K – 598
2025
Q2
$544K Buy
2,486
+120
+5% +$25.7K 0.07% 283
2025
Q1
$530K Buy
2,366
+283
+14% +$78K 0.08% 285
2024
Q4
$682K Sell
2,083
-3
-0.1% -$944 0.1% 217
2024
Q3
$626K Buy
2,086
+146
+8% +$44.7K 0.09% 241
2024
Q2
$639K Buy
1,940
+334
+21% +$118K 0.1% 197
2024
Q1
$636K Buy
1,606
+302
+23% +$112K 0.09% 210
2023
Q4
$459K Buy
1,304
+322
+33% +$114K 0.08% 235
2023
Q3
$368K Buy
982
+541
+123% +$209K 0.16% 149
2023
Q2
$169K Buy
+441
New +$158K 0.12% 161

Other funds holding WST

V-Square Quantitative Management's WST Position: Q3 2026 in Review

V-Square Quantitative Management increased its West Pharmaceutical (WST) stake by 6.8% in Q3 2026, buying an estimated $59K and bringing the position to 2,609 shares worth $967K. The position accounts for 0.09% of the portfolio, ranked #201.

V-Square Quantitative Management first reported a position in WST in Q2 2023 and has held it in 13 quarters since. 140 funds tracked by Wall St. Rank hold WST as of Q3 2026.

  • V-Square Quantitative Management held 2,609 shares of West Pharmaceutical worth $967K as of Q3 2026.
  • V-Square Quantitative Management bought 167 West Pharmaceutical shares in Q3 2026, an estimated $59K.
  • West Pharmaceutical made up 0.09% of V-Square Quantitative Management's portfolio in Q3 2026, its #201 holding.
  • V-Square Quantitative Management first reported a position in West Pharmaceutical in Q2 2023 and has held it in 13 quarters since.
  • 140 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.